<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2020.106164</article-id><article-id pub-id-type="publisher-id">ACM-36213</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20200600000_97712928.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  同源结构域相互作用蛋白激酶2 (HIPK2)对博来霉素诱导小鼠肺纤维化的影响
  The Effect of HIPK2 on Bleomycin-Induced Pulmonary Fibrosis in Mice
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>亚楠</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>于</surname><given-names>文成</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>青岛大学附属医院呼吸与危重症医学科，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>29</day><month>05</month><year>2020</year></pub-date><volume>10</volume><issue>06</issue><fpage>1091</fpage><lpage>1096</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    目的：探讨HIPK2对博来霉素诱导的肺纤维化小鼠的影响。方法：成功构建博来霉素诱导的肺纤维化小鼠模型，构建稳定过表达HIPK2腺病毒载体，设为对照组、模型组和过表达HIPK2组，每组各5只，对肺组织进行HE和Masson染色，并用RT-PCR、Western Blot法测定肺组织中HIPK2和α-SMA含量。结果：博来霉素诱导肺纤维化小鼠模型中HIPK2表达下调(P &lt; 0.05)，α-SMA表达上调(P &lt; 0.05)，且纤维化程度加重；过表达HIPK2可抑制成纤维细胞的激活，使α-SMA表达下调(P &lt; 0.05)，且肺纤维化程度减轻。结论：HIPK2缺乏在肺纤维化机制中具有重要作用，HIPK2可抑制成纤维细胞的激活，减轻肺纤维化。
    Objective: To explore the effect of HIPK2 on bleomycin-induced pulmonary fibrosis in mice. Methods: A mouse model of bleomycin-induced pulmonary fibrosis was successfully constructed, and a stable overexpressing HIPK2 adenovirus vector was constructed. 15 mice were divided into Mock group, Ad-Control group, and Ad-HIPK2 group. HE Masson staining was performed on the lung tissue. The expression of mRNA and protein of HIPK2 and α-SMA were used RT-PCR, Western Blot method. Results: The expression of HIPK2 in Bleomycin-induced pulmonary fibrosis mouse was down-regulated (P &lt; 0.05), α-SMA expression up-regulated (P &lt; 0.05), and the degree of fibrosis increased; overexpression of HIPK2 can inhibit fibroblast activation, down-regulate the expression of α-SMA (P &lt; 0.05), and the degree of pulmonary fibrosis was reduced. Conclusion: HIPK2 deficiency plays an important role in the mechanism of pulmonary fibrosis. HIPK2 can inhibit the activation of fibroblasts and reduce pulmonary fibrosis. 
  
 
</p></abstract><kwd-group><kwd>同源结构域相互作用蛋白激酶2，肺纤维化，博来霉素，小鼠, HIPK2</kwd><kwd> Pulmonary Fibrosis</kwd><kwd> Bleomycin</kwd><kwd> Mice</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>同源结构域相互作用蛋白激酶2 (HIPK2)对博来霉素诱导小鼠肺纤维化的影响<sup> </sup></title><p>张亚楠，于文成</p><p>青岛大学附属医院呼吸与危重症医学科，山东 青岛</p><p>收稿日期：2020年5月25日；录用日期：2020年6月15日；发布日期：2020年6月22日</p><disp-formula id="hanspub.36213-formula49"><graphic xlink:href="//html.hanspub.org/file/34-1571365x5_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>目的：探讨HIPK2对博来霉素诱导的肺纤维化小鼠的影响。方法：成功构建博来霉素诱导的肺纤维化小鼠模型，构建稳定过表达HIPK2腺病毒载体，设为对照组、模型组和过表达HIPK2组，每组各5只，对肺组织进行HE和Masson染色，并用RT-PCR、Western Blot法测定肺组织中HIPK2和α-SMA含量。结果：博来霉素诱导肺纤维化小鼠模型中HIPK2表达下调(P &lt; 0.05)，α-SMA表达上调(P &lt; 0.05)，且纤维化程度加重；过表达HIPK2可抑制成纤维细胞的激活，使α-SMA表达下调(P &lt; 0.05)，且肺纤维化程度减轻。结论：HIPK2缺乏在肺纤维化机制中具有重要作用，HIPK2可抑制成纤维细胞的激活，减轻肺纤维化。</p><p>关键词 :同源结构域相互作用蛋白激酶2，肺纤维化，博来霉素，小鼠</p><disp-formula id="hanspub.36213-formula50"><graphic xlink:href="//html.hanspub.org/file/34-1571365x6_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2020 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/34-1571365x7_hanspub.png" /> <img src="//html.hanspub.org/file/34-1571365x8_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>肺纤维化是一种慢性、进行性、致死性的肺间质疾病，其病因不明，且发病率逐年增加 [<xref ref-type="bibr" rid="hanspub.36213-ref1">1</xref>]，该病更常见于男性及吸烟患者，中位生存期平均3~5年，IPF患者的治疗选择有限，肺移植是唯一可以明显改善患者生存率的治疗方法 [<xref ref-type="bibr" rid="hanspub.36213-ref2">2</xref>]。因此，探讨IPF的发病机制，寻找新的治疗靶点及针对新的靶点的治疗药物，是今后IPF研究的关键。同源结构域相互作用蛋白激酶-2 (HIPK2)是一种通过调节各种基因和信号分子，HIPK2的缺乏在成纤维细胞行为和IPF发病机理中具有重要作用 [<xref ref-type="bibr" rid="hanspub.36213-ref3">3</xref>]。本实验建立博来霉素诱导肺纤维化小鼠模型，观察上调HIPK2对小鼠肺纤维化程度及间质标志物α-SMA的影响。</p></sec><sec id="s4"><title>2. 材料和方法</title><sec id="s4_1"><title>2.1. 材料</title><p>8周龄的SPF级雄性C57BL/6小鼠，体重每只约20 g (北京中国医学科学院实验动物研究所提供)；anti-HIPK2、anti-α-SMA、anti-GAPDH (Abcam，美国)，本次动物实验获得青岛大学动物实验伦理委员会许可。</p></sec><sec id="s4_2"><title>2.2. 方法</title><sec id="s4_2_1"><title>2.2.1. 构建腺病毒载体</title><p>合成和测序目的基因，对目的基因和载体进行连接，热休克法转化感受态大肠杆菌，取其中的单克隆菌落培养并提取质粒，在酶切后对其进行测序，成功构建pAdTrack-CMV/HIPK2、pAdTrack-U6/sh-HIPK2。纯化质粒并将重组腺病毒载体转染293A细胞并且大量扩增，建带有GFP示踪基因的Ad-HIPK2腺病毒载体，鉴定正确后进行扩增、浓缩纯化，并测定腺病毒的滴度，用于实验。</p></sec><sec id="s4_2_2"><title>2.2.2. 构建动物模型</title><p>将15只C57小鼠，随机分3组，每组5只，具体分组情况如下：A：对照组(Mock组) B：模型组(Ad-control组) C：模型组+HIPK2过表达组(Ad-HIPK2组)。将70 uL博莱霉素溶液(浓度为1 mg/mL，剂量约为3.5 mg/kg)滴入小鼠气管进行肺纤维化造模，对照组使用等体积无菌生理盐水，常规SPF级动物房喂养。造模次日于小鼠尾静脉注射相应的腺病毒(5 &#215; 10<sup>9</sup> PFU/只)。实验过程中观察小鼠饮食情况，于第7天处死实验小鼠，收集肺组织。</p></sec><sec id="s4_2_3"><title>2.2.3. 模型纤维化评估</title><p>将固定24 h的肺组织常规脱水、透明、浸蜡、包埋，制作5 μm厚的连续切片，每片相距30 μm，用苏木精–伊红(HE)染色进行结构观察，用Masson染色检测胶原沉积，高倍镜下拍照，200&#215;。于显微镜下观察肺组织纤维化程度。</p></sec><sec id="s4_2_4"><title>2.2.4. RT-PCR测定肺组织HIPK2、α-SMA的含量</title><p>研磨肺组织、裂解、过滤并离心提取总RNA，并逆转录获得cDNA。荧光定量PCR扩增待检测基因和内参β-actin，使用表1所示的引物进行PCR反应。循环温度为：94℃ 4 min, 94℃ 30 s、56℃ 30 s、72℃ 30 s 40个循环。</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Primer sequences used for PCR analysi</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >引物名称</th><th align="center" valign="middle" >正向引物</th><th align="center" valign="middle" >反向引物</th><th align="center" valign="middle" >产物长度(bp)</th></tr></thead><tr><td align="center" valign="middle" >HIPK2</td><td align="center" valign="middle" >5’CAGCAACACCAGCCCCTA3’</td><td align="center" valign="middle" >5’GGACTTGAAGGAGGACGAA3’</td><td align="center" valign="middle" >214</td></tr><tr><td align="center" valign="middle" >α-SMA</td><td align="center" valign="middle" >5’GTACCCAGGCATTGCTGACA3’</td><td align="center" valign="middle" >5’GAGGCGCTGATCCACAAAAC3’</td><td align="center" valign="middle" >271</td></tr></tbody></table></table-wrap><p>表1. 用于PCR分析的引物序列</p></sec><sec id="s4_2_5"><title>2.2.5. Western Blot检测肺组织中HIPK2、α-SMA的表达变化</title><p>RIPA裂解液裂解肺组织，收集总蛋白，BAC法测定各样品蛋白质浓度，SDS-PAGE凝胶电泳，PVDF膜转膜，2%的BSA中封闭，分别用anti-HIPK2、anti-α-SMA、anti-GAPDH孵育膜，辣根过氧化酶(HRP)标记的二抗(天津赛尔，中国)进行孵育，洗涤后用化学发光法显色，在暗室曝光并进行显影、定影处理，用Lab Works<sup>TM</sup>凝胶成像及分析系统扫描所有胶片，分析各蛋白条带的亮度值，计算校正后的目的蛋白相对表达量。</p><p>图1. HIPK2在各组小鼠中的表达情况。A：通过qPCR检测HIPK2 mRNA表达。B Western blot 检测HIPK2蛋白表达。<sup>*</sup>：与Ad-control组相比，p &lt; 0.05，n = 5</p></sec><sec id="s4_2_6"><title>2.2.6. 统计学分析</title><p>采用SPSS 22.0统计软件，两组间均数的比较采用单因素方差分析的Dunnet事后比较，实验数据以 x &#175; &#177; s 表示，P &lt; 0.05时差异有统计学意义。</p></sec></sec></sec><sec id="s5"><title>3. 结果</title><sec id="s5_1"><title>3.1. HIPK2在肺纤维化小鼠体内低表达</title><p>RT-PCR和Western Blot检测显示(图1)，与Mock组相比，HIPK2的mRNA和蛋白表达在博来霉素诱导的肺纤维化小鼠模型组中是低表达的；Ad-HIPK2组可稳定过表达HIPK2，p &lt; 0.05，n = 5。</p></sec><sec id="s5_2"><title>3.2. HIPK2能减轻博来霉素诱导小鼠肺纤维化程度</title><p>HE和Masson染色可见(图2)，与Mock组相比，模型组肺纤维化程度加重；与模型组相比，HIPK2过表达组纤维化程度减轻。</p><p>图2. 各组小鼠肺组织HE和Masson染色，200&#215;</p><p>图3. α-SMA在各组小鼠中的表达情况。A：RT-PCR检测α-SMA mRNA表达，B：Western blot检测α-SMA蛋白表达。<sup>*</sup>：与Ad-control组相比，p &lt; 0.05，n = 5</p></sec><sec id="s5_3"><title>3.3. HIPK2能抑制成纤维细胞的活化</title><p>RT-PCR和Western Blot检测显示(图3)，与Mock组相比，模型组中α-SMA的mRNA和蛋白表达增加；Ad-HIPK2组较模型组减少，p &lt; 0.05，n = 5。</p></sec></sec><sec id="s6"><title>4. 讨论</title><p>目前认为肺纤维化的病理学过程表现为在各种致纤维化因素作用下，肺泡上皮细胞弥漫性损伤，激活成纤维细胞，大量分泌胶原纤维，胶原纤维等细胞外基质的异常沉积引起组织收缩，最终发展成为广泛的纤维化变化 [<xref ref-type="bibr" rid="hanspub.36213-ref4">4</xref>] [<xref ref-type="bibr" rid="hanspub.36213-ref5">5</xref>]。</p><p>同源结构域相互作用蛋白激酶2 (HIPK 2)是保守的丝氨酸/苏氨酸同源结构域相互作用激酶家族的一部分，是一种重要的转录辅助调节蛋白 [<xref ref-type="bibr" rid="hanspub.36213-ref6">6</xref>] [<xref ref-type="bibr" rid="hanspub.36213-ref7">7</xref>]。研究发现HIPK 2有多种功能，包括转录因子的共同调节、生长、发育、形态发生和细胞死亡的调控、肿瘤抑制和DNA损伤反应的调节 [<xref ref-type="bibr" rid="hanspub.36213-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.36213-ref9">9</xref>]。HIPK在癌症和慢性纤维化中已成为有希望的药物靶点 [<xref ref-type="bibr" rid="hanspub.36213-ref10">10</xref>]。研究发现，HIPK2通过调节促凋亡、促纤维化和促炎症通路，被认为是肾纤维化的重要驱动因素，可能是抗纤维药物的潜在靶点 [<xref ref-type="bibr" rid="hanspub.36213-ref11">11</xref>]。尚有研究发现，HIPK2参与Sigma-1受体在二氧化硅致纤维化中的调控作用 [<xref ref-type="bibr" rid="hanspub.36213-ref12">12</xref>]。对于HIPK2在博来霉素诱导的肺纤维化模型小鼠中研究较少。</p><p>我们构建了博来霉素诱导的肺纤维化小鼠模型，证明HIPK2在纤维化肺组织中是低表达的；同时构建稳定过表达HIPK2的腺病毒载体，通过染色发现转染该载体的小鼠肺组织肺纤维化程度较模型组减轻，且其间质标志物α-SMA表达下降，说明过表达HIPK2能抑制成纤维细胞的活化。我们的研究与Ricci等人相符，其证实IPF人成纤维细胞HIPK2表达降低，认为肺成纤维细胞中HIPK2基因的缺失可能会抑制P53的活化，从而促进了肺成纤维细胞的凋亡，促进肺纤维化的发生 [<xref ref-type="bibr" rid="hanspub.36213-ref3">3</xref>]。我们从体内实验明确了HIPK2在纤维化肺组织内的表达情况，并证实过表达HIPK2可减轻肺纤维化。下一步，我们将设立体外实验进一步探究HIPK2减轻肺纤维化的具体机制，为治疗提供更新的靶点。</p></sec><sec id="s7"><title>文章引用</title><p>张亚楠,于文成. 同源结构域相互作用蛋白激酶2 (HIPK2)对博来霉素诱导小鼠肺纤维化的影响The Effect of HIPK2 on Bleomycin-Induced Pulmonary Fibrosis in Mice[J]. 临床医学进展, 2020, 10(06): 1091-1096. https://doi.org/10.12677/ACM.2020.106164</p></sec><sec id="s8"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.36213-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Hutchinson, J., et al. (2015) Global Incidence and Mortality of Idiopathic Pulmonary Fibrosis: A Systematic Review. European Respiratory Journal, 46, 795-806. &lt;br&gt;https://doi.org/10.1183/09031936.00185114</mixed-citation></ref><ref id="hanspub.36213-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Raghu, G., et al. (2018) Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine, 198, e44-e68.</mixed-citation></ref><ref id="hanspub.36213-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Ricci, A., et al. (2013) Homeodomain-Interacting Protein Kinase2 in Human Idiopathic Pulmonary Fibrosis. Journal of Cellular Physiology, 228, 235-241. &lt;br&gt;https://doi.org/10.1002/jcp.24129</mixed-citation></ref><ref id="hanspub.36213-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Wuyts, W.A., et al. (2013) The Pathogenesis of Pulmonary Fibrosis: A Moving Target. European Respiratory Journal, 41, 1207-1218. &lt;br&gt;https://doi.org/10.1183/09031936.00073012</mixed-citation></ref><ref id="hanspub.36213-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Parker, M.W., et al. (2014) Fibrotic Extracellular Matrix Activates a Profibrotic Positive Feedback Loop. The Journal of Clinical Investigation, 124, 1622-1635. &lt;br&gt;https://doi.org/10.1172/JCI71386</mixed-citation></ref><ref id="hanspub.36213-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Lee, S., et al. (2016) Activation of HIPK2 Promotes ER Stress-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis. Neuron, 91, 41-55. &lt;br&gt;https://doi.org/10.1016/j.neuron.2016.05.021</mixed-citation></ref><ref id="hanspub.36213-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Hashimoto, K. and Tsuji, Y. (2017) Arsenic-Induced Activation of the Homeodomain-Interacting Protein Kinase 2 (HIPK2) to cAMP-Response Element Binding Protein (CREB) Axis. Journal of Molecular Biology, 429, 64-78.  
&lt;br&gt;https://doi.org/10.1016/j.jmb.2016.11.015</mixed-citation></ref><ref id="hanspub.36213-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Kuwano, Y., et al. (2016) Homeodomain-Interacting Protein Kinase-2: A Critical Regulator of the DNA Damage Response and the Epigenome. International Journal of Molecular Sciences, 17, 1638.  
&lt;br&gt;https://doi.org/10.3390/ijms17101638</mixed-citation></ref><ref id="hanspub.36213-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Gatti, V., et al. (2020) An Alternative Splice Variant of HIPK2 with Intron Retention Contributes to Cytokinesis. Cells, 9, 484. &lt;br&gt;https://doi.org/10.3390/cells9020484</mixed-citation></ref><ref id="hanspub.36213-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Agnew, C., et al. (2019) The Crystal Structure of the Protein Kinase HIPK2 Reveals a Unique Architecture of Its CMGC-Insert Region. Journal of Biological Chemistry, 294, 13545-13559. &lt;br&gt;https://doi.org/10.1074/jbc.RA119.009725</mixed-citation></ref><ref id="hanspub.36213-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Xiong, C., et al. (2016) Pharmacological Targeting of BET Proteins Inhibits Renal Fibroblast Activation and Alleviates Renal Fibrosis. Oncotarget, 7, 69291-69308. &lt;br&gt;https://doi.org/10.18632/oncotarget.12498</mixed-citation></ref><ref id="hanspub.36213-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Cao, Z., et al. (2017) CircHIPK2-Mediated σ-1R Promotes Endoplasmic Reticulum Stress in Human Pulmonary Fibroblasts Exposed to Silica. Cell Death &amp; Disease, 8, Article No. 3212. &lt;br&gt;https://doi.org/10.1038/s41419-017-0017-4</mixed-citation></ref></ref-list></back></article>